Literature DB >> 11466121

Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors.

B Crespo-Facorro1, S Paradiso, N C Andreasen, D S O'Leary, G L Watkins, L L Ponto, R D Hichwa.   

Abstract

CONTEXT: Loss of the capacity to experience pleasure (anhedonia) is a core clinical feature of schizophrenia. Although functional imaging techniques have been successful in identifying the neural basis of cognitive impairments in schizophrenia, no attempts to date have been made to investigate neural systems underlying emotional disturbances.
OBJECTIVE: To study the neural basis of emotional processing in schizophrenia by exploring the pattern of brain responses to olfactory stimuli in patients and healthy volunteers.
DESIGN: Positron emission tomographic study of patients with schizophrenia and healthy volunteers. Positron emission tomographic data were collected between July 21, 1995, and September 11, 1997, and data analyses were conducted in 1999-2001.
SETTING: The Mental Health Clinical Research Center at the University of Iowa, Iowa City. PARTICIPANTS: Sixteen healthy volunteers with a mean age of 29.5 years and 18 patients with schizophrenia and a mean age of 30.0 years. MAIN OUTCOME MEASURE: Areas of relative increase or decrease in regional cerebral blood flow, measured using positron emission tomography and the [(15)O]water method while participants performed an emotion-induction olfactory task to determine response to pleasant (vanillin) and unpleasant (4-methylvaleric acid) odors, compared between patients and healthy volunteers.
RESULTS: Patients with schizophrenia subjectively experienced unpleasant odors in a manner similar to healthy volunteers but showed impairment in the experience of pleasant odors. The analysis of the regional cerebral blood flow revealed that patients failed to activate limbic/paralimbic regions (eg, insular cortex, nucleus accumbens, and parahippocampal gyrus) during the experience of unpleasant odors, recruiting a compensatory set of frontal cortical regions instead.
CONCLUSION: Abnormalities in the complex functional interactions between mesolimbic and frontal regions may underlie emotional disturbances in schizophrenia.

Entities:  

Mesh:

Year:  2001        PMID: 11466121     DOI: 10.1001/jama.286.4.427

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  72 in total

Review 1.  Scent of a disorder: olfactory functioning in schizophrenia.

Authors:  Paul J Moberg; Bruce I Turetsky
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

Review 2.  The neural circuitry of reward and its relevance to psychiatric disorders.

Authors:  David T Chau; Robert M Roth; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

3.  Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.

Authors:  E C Muly; J R Votaw; J Ritchie; L L Howell
Journal:  J Pharmacol Exp Ther       Date:  2012-01-03       Impact factor: 4.030

4.  Patients with schizophrenia demonstrate inconsistent preference judgments for affective and nonaffective stimuli.

Authors:  Gregory P Strauss; Benjamin M Robinson; James A Waltz; Michael J Frank; Zuzana Kasanova; Ellen S Herbener; James M Gold
Journal:  Schizophr Bull       Date:  2010-05-19       Impact factor: 9.306

Review 5.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

6.  Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies.

Authors:  Alan Anticevic; Jared X Van Snellenberg; Rachel E Cohen; Grega Repovs; Erin C Dowd; Deanna M Barch
Journal:  Schizophr Bull       Date:  2010-12-01       Impact factor: 9.306

7.  Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia.

Authors:  James A Waltz; Julie B Schweitzer; Thomas J Ross; Pradeep K Kurup; Betty J Salmeron; Emma J Rose; James M Gold; Elliot A Stein
Journal:  Neuropsychopharmacology       Date:  2010-08-18       Impact factor: 7.853

8.  Sex differences, hormones, and fMRI stress response circuitry deficits in psychoses.

Authors:  Jill M Goldstein; Katie Lancaster; Julia M Longenecker; Brandon Abbs; Laura M Holsen; Sara Cherkerzian; Susan Whitfield-Gabrieli; Nicolas Makris; Ming T Tsuang; Stephen L Buka; Larry J Seidman; Anne Klibanski
Journal:  Psychiatry Res       Date:  2015-03-31       Impact factor: 3.222

9.  Eyeblink conditioning in unmedicated schizophrenia patients: a positron emission tomography study.

Authors:  Krystal L Parker; Nancy C Andreasen; Dawei Liu; John H Freeman; Daniel S O'Leary
Journal:  Psychiatry Res       Date:  2013-10-01       Impact factor: 3.222

10.  Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators.

Authors:  Erin C Dowd; Deanna M Barch
Journal:  Biol Psychiatry       Date:  2009-12-09       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.